Marinus van Hulst

10PUBLICATIONS
26CO-AUTHORS
Economic models and forecastingEpidemiological methodsAboriginal and Torres Strait Islander cultural determinants of healthModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 20, 2025
A review of methodological aspects of economic evaluations used in NICE assessments for treatments in metastatic breast cancer.

Jeroen Hendrikus Jacobus Paulissen, Sharon Wolters, Arjan Jacobus Postma

|Apr 26, 2025
Cost-Effectiveness of Screening and Treating Chronic Hepatitis C Virus Infection in Zimbabwe.

Blessing Dzingirai, Leolin Katsidzira, Maarten J Postma

|Apr 03, 2025
Seroprevalence and demographic characteristics of SARS-CoV-2-infected residents of Kibera informal settlement during the COVID-19 pandemic in Nairobi, Kenya: a cross-sectional study.

Jane Y Carter, Samoel Khamadi, Joseph Mwangi

|Nov 12, 2024
Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy.

Jeroen Hendrikus Jacobus Paulissen, Alexander Victor van Schoonhoven, Emma Olin

|May 10, 2024
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review.

Clazinus Veijer, Marinus H van Hulst, Benjamin Friedrichson

|Jul 24, 2023
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland.

Jeroen H J Paulissen, Ahmed H Seddik, Kyle J Dunton

Pageof 2

Frequent Collaborators

5 joint publications

Maarten Postma

3 joint publications

Jeroen Hendrikus Jacobus Paulissen

2 joint publications

Maartje S Jacobs

2 joint publications

Roel Donald Freriks